Very Early PET-response Adapted Targeted Therapy for Advanced Hodgkin Lymphoma: a Single -Arm Phase II Study
Clinical trial NCT03517137 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03517137
- Sponsor
- European Organisation for Research and Treatment of Cancer - EORTC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-01
- Primary completion
- 2023-08-28
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.